Antioxidant inhibition of protein kinase C—signaled increases in transforming growth factor-beta in mesangial cells

• Published in: Metabolism, clinical and experimental Vol. 46; no. 8; pp. 918 - 925
• Main Authors: Studer, R.K., Craven, P.A., Derubertis, F.R.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.08.1997; Elsevier
• Subjects: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcysteine - pharmacology; Angiotensin II - physiology; Animals; Antioxidants - pharmacology; Associated diseases and complications; Biological and medical sciences; Cells, Cultured; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Enzyme Activation - drug effects; Female; Glucose - physiology; Kidney Glomerulus - cytology; Kidney Glomerulus - metabolism; Medical sciences; Phorbol 12,13-Dibutyrate - pharmacology; Prostaglandin Endoperoxides, Synthetic - pharmacology; Protein Kinase C - drug effects; Rats; Rats, Sprague-Dawley; Taurine - pharmacology; Thromboxane A2 - analogs & derivatives; Thromboxane A2 - pharmacology; Thromboxanes - physiology; Transforming Growth Factor beta - antagonists & inhibitors; Vitamin E - pharmacology; Cell culture; Protein kinase C; Peptides; Rat; Enzyme; Mesangial cell; Transforming growth factor β; Transferases; Rodentia; α-Tocopherol; Antioxidant; Biological activity; Vertebrata; Hyperglycemia; Mammalia; Protein synthesis; Animal; Biological effect; Thromboxane; Angiotensin II
• ISSN: 0026-0495; 1532-8600
• DOI: 10.1016/S0026-0495(97)90080-9

Protein kinase C (PKC)-signaled increases in transforming growth factor β (TGFβ) have been implicated in the stimulation of matrix protein synthesis induced by high concentrations of glucose, thromboxane, angiotension II (All), and other stimuli in cultured glomerular mesangial cells. In the present study, the effects of several antioxidants on mesangial cell responses to high glucose, thromboxane, and All were examined. α-Tocopherol blocked increases in PKC, TGFβ bioactivity, collagen, and/or fibronectin synthesis induced in mesangial cells by high glucose, the thromboxane analog U46619, and All. By contrast, α-tocopherol did not alter increases in matrix protein synthesis in mesangial cells in response to exogenous TGFIβ, a cytokine that does not activate PKC in mesangial cells and whose actions to stimulate matrix protein synthesis in these cells are not blocked by PKC inhibition or downregulation. Taurine and N-acetylcysteine similarly inhibited activation of PKC and increases in TGFβ in response to high glucose, U46619, and All, α-Tocopherol but not taurine or N-acetylcysteine partially blocked increases in PKC activity in mesangial cells in response to the diacylglycerol (DAG) analog, phorbol dibutyrate (PDBu). Thus, α-tocopherol may have direct effects on interaction of the PKC system of mesangial cells with DAG that are not shared by N-acetylcysteine or taurine. Increases in TGFβ have been implicated in the pathogenesis of glomerulosclerosis in diabetes and other nephropathies. The capacity of antioxidants to block increases in TGFβ in mesangial cells in response to high glucose, thromboxane, and All suggests their potential therapeutic utility to attenuate glomerulosclerosis.